Abstract:Prion diseases are fatal neurodegenerative disorders that affect humans and animals, and can also be transmitted from animals to humans. A fundamental event in prion disease pathogenesis is the conversion of normal host prion protein (PrPC) to a disease-associated misfolded form (PrPSc). Whether or not an animal prion disease can infect humans cannot be determined a priori. There is a consensus that classical bovine spongiform encephalopathy (C-type BSE) in cattle transmits to humans, and that classical sheep scrapie is of little or no risk to human health. However, the zoonotic potential of more recently identified animal prion diseases, such as atypical scrapie, H-type and L-type BSE and chronic wasting disease (CWD) in cervids, remains an open question. Important components of the zoonotic barrier are (i) physiological differences between humans and the animal in question, (ii) amino acid sequence differences of the animal and human PrPC, and (iii) the animal prion strain, enciphered in the conformation of PrPSc. Historically, the direct inoculation of experimental animals has provided essential information on the transmissibility and compatibility of prion strains. More recently, cell-free molecular conversion assays have been used to examine the molecular compatibility on prion replication and zoonotic potential. One such assay is Protein Misfolding Cyclic Amplification (PMCA), in which a small amount of infected tissue homogenate, containing PrPSc, is added as a seed to an excess of normal tissue homogenate containing PrPC, and prion conversion is accelerated by cycles of incubation and ultrasonication. PMCA has been used to measure the molecular feasibility of prion transmission in a range of scenarios using genotypically homologous and heterologous combinations of PrPSc seed and PrPC substrate. Furthermore, this method can be used to speculate on the molecular profile of PrPSc that might arise from a zoonotic transmission. We discuss the experimental approaches that have been used to model both the intra- and inter-species molecular compatibility of prions, and the factors affecting PrPc to PrPSc conversion and zoonotic potential. We conclude that cell-free prion protein conversion assays, especially PMCA, are useful, rapid and low-cost approaches for elucidating the mechanisms of prion propagation and assessing the risk of animal prions to humans.

What is the role of lipids in prion conversion and disease?

Cell-Free Conversion of Prion Proteins

Interactions between Cytokines and the Pathogenesis of Prion Diseases: Insights and Implications

Mechanisms of prion-induced toxicity

Conformational Conversion of Prion Protein in Prion Diseases.

PrP(Sc) of Scrapie 263K Propagates Efficiently in Spleen and Muscle Tissues with Protein Misfolding Cyclic Amplification.

Post-translational modifications in prion diseases

Prions Mediated Neurodegenerative Disorders.

Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions.

Prion Protein Misfolding, Strains, and Neurotoxicity: An Update from Studies on Mammalian Prions

Prion Protein Oligomer and Its Neurotoxicity

Prions and protein-folding diseases

Understanding Intra-Species and Inter-Species Prion Conversion and Zoonotic Potential Using Protein Misfolding Cyclic Amplification

Targeting Prion-Like Protein Spreading in Neurodegenerative Diseases

Protein-lipid interactions and protein anchoring modulate the modes of association of the globular domain of the Prion protein and Doppel protein to model membrane patches

Exploration Of The Main Sites For The Transformation Of Normal Prion Protein (Prpc) Into Pathogenic Prion Protein (Prpsc)

Exploration of the main sites for the transformation of normal prion protein (PrP<sup>C</sup>) into pathogenic prion protein (PrP<sup>sc</sup>)

Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion

The allure and pitfalls of the prion-like aggregation in neurodegeneration

Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases

Autophagy and Prion Disease